| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Larry I Lipshultz | |
| Mohit Khera | |||
| P2860 | cites work | Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats | Q28212065 |
| Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia | Q34278601 | ||
| Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone | Q34299887 | ||
| Prevalence of hypogonadism in males aged at least 45 years: the HIM study | Q35037892 | ||
| Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men. | Q35862931 | ||
| Testosterone therapy in erectile dysfunction and hypogonadism | Q36372421 | ||
| Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial | Q38402163 | ||
| The effect of parenteral testosterone replacement on prostate specific antigen in hypogonadal men with erectile dysfunction | Q39454488 | ||
| Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less | Q39778629 | ||
| Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer | Q39790327 | ||
| Delayed testosterone replacement restores nitric oxide synthase-containing nerve fibres and the erectile response in rat penis | Q41733570 | ||
| Effect of testosterone on the number of NADPH diaphorase-stained nerve fibers in the rat corpus cavernosum and dorsal nerve | Q41758101 | ||
| Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens | Q43597840 | ||
| The relationship between testosterone levels, the metabolic syndrome (by two criteria), and insulin resistance in a population of men with organic erectile dysfunction | Q43738766 | ||
| Effects of Medical or Surgical Castration on Erectile Function in an Animal Model | Q44422784 | ||
| Androgen and estrogen receptors in the human corpus cavernosum penis: immunohistochemical and cell culture results | Q44637416 | ||
| Blood testosterone threshold for androgen deficiency symptoms | Q45006018 | ||
| Testosterone replacement therapy after primary treatment for prostate cancer | Q45219185 | ||
| Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. | Q45267265 | ||
| Dihydrotestosterone is the active androgen in the maintenance of nitric oxide-mediated penile erection in the rat. | Q46611218 | ||
| Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy | Q46715554 | ||
| Adjunctive use of AndroGel (testosterone gel) with sildenafil to treat erectile dysfunction in men with acquired androgen deficiency syndrome after failure using sildenafil alone | Q46983479 | ||
| Localization of androgen receptor in nitric oxide synthase- and vasoactive intestinal peptide-containing neurons of the major pelvic ganglion innervating the rat penis. | Q50531012 | ||
| Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. | Q50961169 | ||
| Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. | Q52042770 | ||
| Effects of Castration and Androgen Replacement on Erectile Function in a Rabbit Model1 | Q57576172 | ||
| Androgen-dependent nitric oxide release in rat penis correlates with levels of constitutive nitric oxide synthase isoenzymes. | Q61978105 | ||
| Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men | Q70498343 | ||
| Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls | Q71624041 | ||
| Is low serum free testosterone a marker for high grade prostate cancer? | Q73477251 | ||
| Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer | Q73927020 | ||
| Effects of androgens on the expression of nitric oxide synthase mRNAs in rat corpus cavernosum | Q77418722 | ||
| The effect of androgen status on the structural and functional success of cavernous nerve grafting in an experimental rat model | Q79426606 | ||
| Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy | Q79446008 | ||
| Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy | Q80107152 | ||
| P433 | issue | 4 | |
| P921 | main subject | testosterone | Q1318776 |
| testosterone | Q27863114 | ||
| P304 | page(s) | 549-53, vi | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | Urologic Clinics of North America | Q15767454 |
| P1476 | title | The role of testosterone replacement therapy following radical prostatectomy | |
| P478 | volume | 34 |
| Q37813672 | Androgens, health and sexuality in women and men. |
| Q42729029 | Hypogonadism, ADAM, and hormone replacement |
| Q37299250 | ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males |
| Q46397195 | ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males |
| Q40590766 | Influence of serum testosterone on urinary continence and sexual activity in patients undergoing radical prostatectomy for clinically localized prostate cancer. |
| Q37310024 | Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations |
| Q43253359 | Low-risk prostate cancer and low testosterone: what are the acceptable alternatives? |
| Q39354036 | Prostate magnetic resonance imaging findings in patients treated for testosterone deficiency while on active surveillance for low-risk prostate cancer |
| Q34575573 | Sexual rehabilitation after localized prostate cancer: current interventions and future directions |
| Q45898491 | Suicidal ideation in prostate cancer survivors: understanding the role of physical and psychological health outcomes. |
| Q38913362 | Testosterone Therapy Among Prostate Cancer Survivors. |
| Q38364486 | Testosterone and cardiovascular disease--the controversy and the facts |
| Q24658011 | The benefits and risks of testosterone replacement therapy: a review |
Search more.